Product claims

‘Warning letter geek’ decodes marketing compliance

‘Warning letter geek’ decodes marketing compliance

By Danielle Masterson

Asa Waldstein is principal of the Supplement Advisory Group and the man behind 'Warning Letter Wednesdays.' His bread and butter is educating companies about the dos and don'ts of marketing.

©Getty Images - Artur

FTC proposes new guidelines to hem in use of fake reviews

By Hank Schultz

The US Federal Trade Commission is proposing an updated set of rules that would attempt to rein in the burgeoning use of phony reviews to hawk products online. They would also work to prevent the suppression of negative reviews

©Getty Images - David Trood

FDA slams Delta-8 THC sellers over claims

By Hank Schultz

FDA came down hard on purveyors of Delta-8 THC and CBD products that were making disease claims on the substances. The Agency also reiterated the reasons it believes Delta-8 is not a suitable ingredient for products marketed as supplements.

NutraWomen Wednesday: Pooja Nair, partner at Ervin Cohen & Jessup LLP

NutraWomen Wednesday: Pooja Nair, partner at Ervin Cohen & Jessup LLP

By Danielle Masterson

Attorney Pooja Nair is a Harvard-educated business litigator who has an eagle eye on the food and beverage sector. She advises clients, including restaurant groups, food brands, and manufacturers on a comprehensive range of issues. She is also a noted...

Many of the questionable ingredients touted on the Dr Oz Show related to weight loss. ©Getty Images - Michael Poehlmann

Commentary

Is the supplement industry in for a reverse Dr Oz effect?

By Hank Schultz

The Senate candidacy of Dr Mehmet Oz, MD, could pose a public relations risk for the dietary supplement industry, as the prominent media personality gets attacked for being a ‘quack’ who has promoted questionable products.

Getty Images / altmodern

Navigating the legal landscape of weight loss supplements

By Danielle Masterson

Over 42% of adults in the US are considered obese—giving weight loss brands easy marketing fodder amid the obesity epidemic. Unfortunately, this category of supplements has a checkered history, and has become labeled as one of FDA's problem children.

©Getty Images - serggn

Another phenibut product shows up in warning letter

By Hank Schultz

An FDA warning letter to the marketer of a product containing phenibut took the company to task over noncompliant disease claims but made no mention of the legal status of the ingredient itself.

Follow us

Products

View more

Webinars